Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-30
DOI
10.1038/s41380-021-01228-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Critical Relationship Between Anxiety and Depression
- (2020) Ned H. Kalin AMERICAN JOURNAL OF PSYCHIATRY
- Publisher Correction: Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
- (2020) Lucia Recinella et al. Scientific Reports
- Rodent models of post-traumatic stress disorder: behavioral assessment
- (2020) Alexander Verbitsky et al. Translational Psychiatry
- Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
- (2019) Tania Villanova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth hormone-releasing hormone receptor mediates cytokine production in ciliary and iris epithelial cells during LPS-induced ocular inflammation
- (2019) Jia Lin Ren et al. EXPERIMENTAL EYE RESEARCH
- Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin
- (2019) Chongxu Zhang et al. LUNG
- Protective Effects Induced by Two Polyphenolic Liquid Complexes from Olive (Olea europaea, mainly Cultivar Coratina) Pressing Juice in Rat Isolated Tissues Challenged with LPS
- (2019) Lucia Recinella et al. MOLECULES
- Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat
- (2018) Lucia Recinella et al. Pharmacological Reports
- The Association between Inflammatory Markers (iNOS, HO-1, IL-33, MIP-1β) and Depression with and without Posttraumatic Stress Disorder
- (2018) Ewa A. Ogłodek et al. Pharmacological Reports
- Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis
- (2018) Petra Popovics et al. PROSTATE
- Behavioural phenotyping, learning and memory in young and aged growth hormone-releasing hormone knockout mice
- (2018) Sheila Leone et al. Endocrine Connections
- Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
- (2018) Serena Veschi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Brain circuit dysfunction in post-traumatic stress disorder: from mouse to man
- (2018) Robert J. Fenster et al. NATURE REVIEWS NEUROSCIENCE
- Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
- (2018) Kenji Hashimoto Frontiers in Pharmacology
- P53, GHRH, inflammation and cancer
- (2018) Nektarios Barabutis et al. EBioMedicine
- Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
- (2017) Markus Dold et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
- (2017) Marta Zarandi et al. PEPTIDES
- Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats
- (2017) Sheila Leone et al. Pharmacological Reports
- Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression
- (2017) Chanjuan Zhou et al. PLoS One
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease
- (2016) Miklos Jaszberenyi et al. Aging-US
- Medial Prefrontal-Hippocampal Connectivity and Motor Memory Consolidation in Depression and Schizophrenia
- (2015) Lisa Genzel et al. BIOLOGICAL PSYCHIATRY
- Common biochemical defects linkage between post-traumatic stress disorders, mild traumatic brain injury (TBI) and penetrating TBI
- (2015) Kedar N. Prasad et al. BRAIN RESEARCH
- Increased locomotor and thermogenic activity in mice with targeted ablation of the GHRH gene
- (2015) Sheila Leone et al. GROWTH HORMONE & IGF RESEARCH
- Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
- (2015) Veronica Reinhart et al. NEUROBIOLOGY OF DISEASE
- Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression
- (2015) Indira Mendez-David et al. NEUROSCIENCE LETTERS
- Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
- (2015) R. C. Kessler et al. Epidemiology and Psychiatric Sciences
- Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout mice
- (2014) Sheila Leone et al. GROWTH HORMONE & IGF RESEARCH
- Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer
- (2014) C. D. Fahrenholtz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation
- (2014) Yong Jie Qin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- The hippocampal–prefrontal pathway: The weak link in psychiatric disorders?
- (2013) Bill P. Godsil et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of isolated GH deficiency on adipose tissue, feeding and adipokines in mice
- (2013) Lucia Recinella et al. GROWTH HORMONE & IGF RESEARCH
- Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
- (2013) María Dolores Martín-de-Saavedra et al. PSYCHONEUROENDOCRINOLOGY
- Effects of Growth Hormone–Releasing Hormone on Cognitive Function in Adults With Mild Cognitive Impairment and Healthy Older Adults
- (2012) Laura D. Baker et al. ARCHIVES OF NEUROLOGY
- Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning
- (2012) Gyula Telegdy et al. BEHAVIOURAL BRAIN RESEARCH
- Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice
- (2012) Gyula Telegdy et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice
- (2011) Gyula Telegdy et al. BEHAVIOURAL BRAIN RESEARCH
- Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder
- (2011) Thaddeus W.W. Pace et al. BRAIN BEHAVIOR AND IMMUNITY
- GH replacement therapy in elderly GH-deficient patients: a systematic review
- (2011) Nieke E Kokshoorn et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity
- (2011) J J Rakofsky et al. MOLECULAR PSYCHIATRY
- The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903
- (2011) Michelle Yeung et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A Role for Central Nervous Growth Hormone-Releasing Hormone Signaling in the Consolidation of Declarative Memories
- (2011) Manfred Hallschmid et al. PLoS One
- Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice
- (2010) W. A. Banks et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors
- (2009) Elif Engin et al. PSYCHOPHARMACOLOGY
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
- (2008) Francesco Matrisciano et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence
- (2008) E. Engin et al. NEUROSCIENCE
- Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line
- (2008) N. Barabutis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation